Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ·Healthcare·Biotechnology
$4.14
-0.24%
Mkt Cap $85.49M
Analyst Ratings
Buy
11
Hold
0
Sell
0
Price Target (16 analysts)
$33.00
Range $33.00 – $33.00
Implied Upside
+698.1%
Consensus $33.00 vs current $4.14